Neoadjuvant Goserelin for Triple Negative Breast Cancer

NCT03444025 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Triple Negative

Interventions

DRUG: Goserelin

Sponsor

Kasr El Aini Hospital